News

Celebrating Patient Advocates in Clinical Research and Advocacy

Celebrating Patient Advocates in Clinical Research and Advocacy

1nHealth Celebrates Patient Engagement Leaders

1nHealth, a frontrunner in patient recruitment and enrollment for clinical trials, has recently recognized 25 outstanding individuals with its inaugural Patient Engagement Leaders Award. This award highlights the vital roles these leaders play in transforming how patients participate in research. They are not mere participants; they are essential partners in the clinical research landscape.

Elevating Patient Voices in Clinical Trials

The selected honorees cut across various sectors, including biotech, pharmaceuticals, contract research organizations (CROs), advocacy groups, and clinical site organizations. From over 100 nominations representing more than 50 companies, these 25 winner exemplify commitment and innovation in making clinical trials more accessible and patient-centered. By amplifying patient voices, these leaders are establishing new benchmarks for trust and transparency within the clinical trial process.

Acknowledging the Unsung Heroes

Dan Brenner, Founder & CEO of 1nHealth, shared his insights during the announcement, highlighting how these awards shine a spotlight on the often-overlooked heroes of the industry. “These awards honor individuals who deeply embody the values of authenticity, dedication, and curiosity—qualities that drive impactful change in clinical research,” remarked Brenner.

The Importance of Patient Engagement

Patient engagement is far more than a procedural step; it's critical for the safety and efficacy of future therapies. It demands the hard work and dedication of professionals who strive to make patients feel valued and empowered in their roles within the research process.

Honoring Achievements and Shaping Future Nominations

The complete list of honored leaders, along with their inspiring stories, can be accessed through 1nHealth. The platform continues to expand its efforts by announcing that nominations for the 2026 Patient Engagement Leaders Award will open early next year, promising to further the recognition of impactful leaders in the field.

About 1nHealth

From initial outreach to the final stages of recruitment, 1nHealth has established itself as a key player in patient engagement, fostering successful enrollment through strategic recruitment programs. With over 30,000 patients enrolled in more than 150 studies, 1nHealth is dedicated to bridging enrollment challenges and connecting diverse patient populations with relevant clinical studies.

Contact Information

1nHealth
Ryan Day
904.534.1608

Frequently Asked Questions

What is the Patient Engagement Leaders Award?

The Patient Engagement Leaders Award recognizes individuals who significantly contribute to improving patient participation in clinical trials.

Who can be nominated for the award?

Anyone involved in patient engagement within clinical research can be nominated, including professionals from various sectors such as biotech and advocacy groups.

Why is patient engagement important?

It ensures that trials reflect patient needs, enhances safety and efficacy, and fosters better communication between researchers and participants.

How often does 1nHealth conduct these awards?

1nHealth plans to hold the Patient Engagement Leaders Awards annually, with nominations for the following year typically opening each year in early spring.

What role does 1nHealth play in clinical trials?

1nHealth specializes in patient recruitment and engagement, aiming to connect diverse patient populations to clinical studies and enhance overall trial outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading

Top 5 Most Recently Viewed Articles

TFI International announces dividend increase for shareholders

Updated Category News Views 135

TFI International's Dividend Announcement Recently, TFI International Inc. (NYSE and TSX: TFII), a prominent player in the transportation and logistics sector, made a significant announcement that is likely to please its shareholders. The company has declared a quarterly dividend of US $0.45 per outstanding common share. This payment is set to be made on a specified date...

Continue Reading
David Williamson Takes the Helm as Modern Meadow's CEO

Updated Category News Views 172

David Williamson Steps Up as Modern Meadow's Chief Executive Officer Modern Meadow, renowned for its focus on sustainable materials, has recently appointed David Williamson as its new Chief Executive Officer (CEO). Williamson brings a wealth of experience in material science and biotechnology, and he is set to lead the company into an exciting future. Leadership...

Continue Reading
Explore the Exciting World of Fortnite Account Purchases

Updated Category News Views 116

Explore the Exciting World of Fortnite Account Purchases Buy-fortnite-acc.com is thrilled to unveil its brand-new platform dedicated to Fortnite enthusiasts worldwide. This innovative store is a treasure trove for fans searching for rare accounts, complete with impressive in-game items and skins that enhance gameplay. The Ideal Shopping Experience for Gamers With a focus...

Continue Reading
U.S. Bancorp Reports Strong Q3 Earnings with Mixed Results

Updated Category News Views 50

U.S. Bancorp Reports Strong Q3 Earnings with Mixed Results U.S. Bancorp (NYSE: USB) recently announced its earnings for the third quarter, showcasing a compelling performance amidst fluctuations in the financial landscape. The company's shares have moved higher, reflecting a positive market response. Key Financial Highlights In a promising sign for investors, U.S. Bancorp...

Continue Reading
Comcast's Competitive Edge in the Evolving Media Landscape

Updated Category News Views 161

Understanding Comcast's Competitive Position In the fast-paced and evolving media sector, it's vital for investors and industry observers to have a clear understanding of how companies like Comcast fare against their rivals. This analysis offers a detailed comparison of Comcast (NASDAQ: CMCSA) and its main competitors in the media arena. Through a meticulous examination...

Continue Reading